Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (387)
- Scheduling (national classification system) (168)
- Safety monitoring and information (28)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
768 result(s) found, displaying 676 to 700
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 16 meeting statement
-
Corporate reportsTGA approach to disclosure of commercially confidential information (CCI)
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS, ACMS and the joint ACCS-ACMS
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 14 meeting statement
-
Meeting statementsAdvisory Committee on Non-prescription Medicines, 6 March 2014, meeting statement
-
Meeting statementsThe Australian Therapeutic Goods Advisory Council met for the fourth time on 4 February 2014
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 15 meeting statement
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 295 meeting statement
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS, ACMS and the joint ACCS-ACMS
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 294 meeting statement
-
Meeting statementsAdvisory Committee on Biologicals, Meeting 3 statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 13 meeting statement
-
Corporate reportsFind out when software is classified as an in vitro medical device and how it is regulated.
-
Meeting statementsTherapeutic Goods Committee, 27 August 2013, meeting statement
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 293 meeting statement
-
Meeting statementsThe Australian Therapeutic Goods Advisory Council met for the third time on 6 August 2013
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 14 meeting statement
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 292 meeting statement
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS, ACMS and the joint ACCS-ACMS
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 291 meeting statement
-
Meeting statementsAdvisory Committee on Biologicals, Meeting 2 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 290 meeting statement
-
Meeting statementsAdvisory Committee on Medical Devices, Meeting 12 meeting statement
-
Meeting statementsThe TGA asked the ACMD to consider acceptable levels of sensitivity and specificity for Hepatitis C (HCV) and Human Immunodeficiency Virus (HIV) PoCTs
-
Meeting statementsAdvisory Committee on Non-prescription Medicines, 7 March 2013, meeting statement